China, Aug. 27 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Development and validation of AI-based point-of-care pulmonary embolism (PE) risk assessment/auxiliary diagnostic model: a retrospective study'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600130944
Registration Time: 2026/08/26
Type: Observational study
Primary Sponsor: Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=336956
Published by HT Digital Content Services with permission from Health Daily Digest....